Department of Dermatology, University of Thomas Jefferson, Philadelphia, United States
Review Article
Dark Side of Cancer Therapy: Cancer Treatment Induced Cardiopulmonary Inflammation Fibrosis and Immune Modulation
Author(s): Chellappagounder Thangavel*
Advancements in cancer therapy increased the cancer free survival rates and reduced the malignant related
deaths. Therapeutic options for patients with thoracic cancers include the surgical intervention and combination
of chemotherapy with ionizing radiation. Despite these advances, Cancer Therapy-Related Cardiopulmonary
Dysfunction (CTRCPD) is one of the most undesirable side effects of cancer therapy. Chemo-radiation therapy or
immunotherapy promote acute and chronic cardiopulmonary damage by inducing reactive oxygen species, DNA
damage, inflammation, fibrosis, altering cellular immunity, cardiopulmonary failure, and non-malignant related
deaths among cancer-free patients. CTRCPD is a complex entity with multiple factors involved in this pathogenesis.
Although the mechanisms of cancer therapy induced toxicities are multifactorial, damage to the cardiac and
pu.. Read More»